Pharmacology & Pharmacy

Pharmacology & Pharmacy

ISSN Print: 2157-9423
ISSN Online: 2157-9431
www.scirp.org/journal/pp
E-mail: pp@scirp.org
"The Potential of Cerebrolysin in the Treatment of Schizophrenia"
written by Gonzalo Flores, Marco Atzori,
published by Pharmacology & Pharmacy, Vol.5 No.7, 2014
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Evaluation of the therapeutic potential of cerebrolysin and/or lithium in the male Wistar rat model of Parkinson's disease induced by reserpine
Metabolic Brain …, 2023
[2] The antipsychotic olanzapine reduces memory deficits and neuronal abnormalities in a male rat model of Autism
Castañeda, ME Bringas… - Journal of Chemical …, 2023
[3] Effects of aerobic exercise with simultaneous cerebrolysin drug administration on spatial memory in adult male rat model of Parkinson's disease
Veterinary Clinical Pathology …, 2022
[4] Anti-depressant effect of cerebrolysin in reserpine-induced depression in rats: Behavioral, biochemical, molecular and immunohistochemical evidence
2021
[5] Cerebrolysin ameliorates prefrontal cortex and hippocampus neural atrophy of spontaneous hypertensive rats with hyperglycemia
2020
[6] Нейротрофины (Церебролизин)-перспективный путь в разработке болезньмодифицирующей терапии нервно-психических заболеваний. Обзор (часть 3) …
2019
[7] Cerebrolysin attenuates ethanol-induced spatial memory impairments through inhibition of hippocampal oxidative stress and apoptotic cell death in rats
2019
[8] Subchronic cerebrolysin treatment alleviates cognitive impairments and dendritic arborization alterations of granular neurons in the hippocampal dentate gyrus of rats …
2019
[9] Pregnancies alters spine number in cortical and subcortical limbic brain regions of old rats.
2019
[10] Pregnancies alters spine number in cortical and subcortical limbic brain regions of old rats
2019
[11] Intracerebroventricular administration of growth hormone induces morphological changes in pyramidal neurons of the hippocampus and prefrontal cortex in adult rats
Synapse, 2018
[12] Metabolic syndrome causes recognition impairments and reduced hippocampal neuronal plasticity in rats
Journal of Chemical Neuroanatomy, 2017
[13] Cerebrolysin prevents deficits in social behavior, repetitive conduct, and synaptic inhibition in a rat model of autism
Journal of neuroscience research, 2017
[14] Curcuma longa L. extract improves the cortical neural connectivity during the aging process
Neural regeneration research, 2017
[15] 姜黄提取物对老化过程引起的突触变化及神经保护作用
NEURAL REGENERATION RESEARCH, 2017
[16] Cerebrolysin reduces mechanical allodynia in a rodent model of peripheral inflammation
Neuroscience Letters, 2017
[17] Role of the prefrontal cortex in the neonatal ventral hippocampus lesion, an animal model of schizophrenia
2016
[18] Neuronal and brain morphological changes in animal models of schizophrenia
Behavioural brain research, 2016
[19] Neuronal changes after chronic high blood pressure in animal models and its implication for vascular dementia
Synapse, 2016
[20] Cerebrolysin improves memory and ameliorates neuronal atrophy in spontaneously hypertensive, aged rats
Synapse, 2016
[21] Characterization of Cytoarchitecture of dendrites and fiber neurons using the golgi-cox method: an overview. Chapter 8
2016
[22] Estudio de la morfología neuronal de la corteza prefrontal, el hipocampo y la memoria en ratas de la cepa Wistar, Sprague Dawley y Long Evans tratados con …
2016
[23] Efecto de la cerebrolisina en la citoarquitectura de neuronas piramidales del hipocampo dorsal y ventral de ratas expuestas prenatalmente a ácido valproico como …
2015
[24] Sigma agonist 1, 3 di-o-tolyl-guanidine (DTG) on Schizophrenia and Immobility responses
2015
[25] Effect of Sigma agonist 1, 3 di-o-tolyl-guanidine (DTG) on Squizophrenia and Immobility responses.
Therapeutic Targets for Neurological Diseases, 2015
[26] Нейрокогнітивний дефіцит у хворих на шизофренію та варіанти його корекції
Укра?нський в?сник психоневролог??, 2015
[27] НЕЙРОКОГНІТИВНИЙ ДЕФІЦИТ У ХВОРИХ НА ШИЗО ФРЕ НІЮ ТА ВАРІАНТИ ЙОГО КОРЕКЦІЇ
2015
[28] The sigma agonist 1,3‐Di‐o‐tolyl‐guanidine reduces the morphological and behavioral changes induced by neonatal ventral hippocampus lesion in rats
Synapse, 2015
[29] Effect of sigma agonist 1, 3 di-o-tolyl-guanidine (DTG) on squizophrenia and immobility responses
2015
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top